Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Psychopharmacology of personality disorders: review and emerging issues.

Literature DB >> 11177763

Psychopharmacology of personality disorders: review and emerging issues.

Abstract

Progress with the development of models and general principles of psychopharmacologic management of personality disordered patients is reviewed. Recent research using mood stabilizers and novel antipsychotics are discussed. The effects of these medications on impulsive aggressiveness are supported and the effects are evident early and are independent of the effects on mood, including depression. Research is needed with other personality disorders beyond just borderline personality disorder. Future research must develop measurable outcomes and delineate the causal and temporal relationships between the psychopathologic features of personality disorders.

Entities: Disease Species

Mesh：

Substances：

Year: 2001 PMID： 11177763 DOI： 10.1007/s11920-001-0076-0

Source DB: PubMed Journal: Curr Psychiatry Rep ISSN： 1523-3812 Impact factor: 5.285

23 in total

1. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.

Authors: P H Soloff
Journal: Bull Menninger Clin Date: 1998

2. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder.

Authors: D L Gardner; R W Cowdry
Journal: Am J Psychiatry Date: 1986-04 Impact factor: 18.112

3. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.

Authors: S C Schulz; K L Camlin; S A Berry; J A Jesberger
Journal: Biol Psychiatry Date: 1999-11-15 Impact factor: 13.382

4. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.

Authors: O C Pinto; H S Akiskal
Journal: J Affect Disord Date: 1998-12 Impact factor: 4.839

5. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.

Authors: S J Donovan; J W Stewart; E V Nunes; F M Quitkin; M Parides; W Daniel; E Susser; D F Klein
Journal: Am J Psychiatry Date: 2000-05 Impact factor: 18.112

2. Outcome of crisis intervention for borderline personality disorder and post traumatic stress disorder: a model for modification of the mechanism of disorder in complex post traumatic syndromes.

Authors: Andreas Laddis
Journal: Ann Gen Psychiatry Date: 2010-04-27 Impact factor: 3.455

3. High-dose antipsychotic drug use as a predictor for readmission of inpatients with borderline personality disorder: A retrospective chart review in a Japanese psychiatric hospital.

Authors: Yuji Yamada; Yuma Yokoi; Zui Narita; Naotsugu Hirabayashi
Journal: Neuropsychopharmacol Rep Date: 2020-10-10

3 in total

Psychopharmacology of personality disorders: review and emerging issues.

1. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.

2. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder.

3. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.

4. Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder.

5. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.

6. An open trial of valproate in borderline personality disorder.

Review 7. Pharmacotherapy of personality disorders: conceptual framework and clinical strategies.

8. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.

9. Divalproex sodium as a treatment for borderline personality disorder.

10. Divalproex sodium for impulsive aggressive behavior in patients with personality disorder.

1. Borderline personality disorder: current drug treatments and future prospects.

2. Outcome of crisis intervention for borderline personality disorder and post traumatic stress disorder: a model for modification of the mechanism of disorder in complex post traumatic syndromes.

3. High-dose antipsychotic drug use as a predictor for readmission of inpatients with borderline personality disorder: A retrospective chart review in a Japanese psychiatric hospital.